9
Participants
Start Date
May 1, 2022
Primary Completion Date
January 22, 2024
Study Completion Date
Mayo Clinic, Rochester
Lead Sponsor
Collaborators (1)
Casimir, LLC
UNKNOWN
Astellas Pharma Inc
INDUSTRY
Mayo Clinic
OTHER